Steven Cohen
Point72 Asset Management
Steven Cohen, a Wharton School graduate, is considered one of the top hedge fund managers. He founded SAC Capital (later renamed Point72) in 1992. The firm has posted an annualized return of over 30%; in 2023, its flagship fund returned about 11%.
Stock Trading
All
Buys
Sells
No.
Name
Action
Shares Traded
% Change
Shares Held
Mkt Value (Date)
Report Date
Lens Technology Ord Shs Class H (HK)
6613
Sell
-2.59M
-14.70%
14.92M
$51.88M
2025-08-29
Pliant Therapeutics Inc (US)
PLRX
New
+3.76M
+50.00%
3.76M
$6.17M
2025-08-27
Design Therapeutics Inc (US)
DSGN
Buy
+1.14M
+27.80%
2.94M
$16.27M
2025-08-27
4
Invivyd Inc (US)
IVVD
New
+16.73M
+50.00%
16.73M
$14.57M
2025-08-26
5
Shanghai Henlius Biotech Ord Shs H (HK)
2696
New
+7.79M
+50.00%
7.79M
$77.85M
2025-08-26
6
Avalo Therapeutics Inc (US)
AVTX
New
+588.63K
+50.00%
588.63K
$5.50M
2025-08-04
7
Verastem Inc (US)
VSTM
New
+3.34M
+50.00%
3.34M
$20.60M
2025-07-25
8
Soitec Ord Shs (FR)
SOIT
New
+2.37M
+50.00%
2.37M
$103.53M
2025-07-23
9
Zepp Health Corp (US)
ZEPP
New
+404.51K
+50.00%
404.51K
$5.44M
2025-07-17
10
Nokia Oyj (US)
NOK
Buy
+19.44M
+48.40%
20.69M
$107.15M
2025-06-30
